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ZebraﬁshNucleostemin (NS), a member of a family of nucleolar GTP-binding proteins, is highly expressed in
proliferating cells such as stem and cancer cells and is involved in the control of cell cycle progression. Both
depletion and overexpression of NS result in stabilization of the tumor suppressor p53 protein in vitro.
Although it has been previously suggested that NS has p53-independent functions, these to date remain
unknown. Here, we report two zebraﬁsh mutants recovered from forward and reverse genetic screens that
carry loss of function mutations in twomembers of this nucleolar protein family, Guanine nucleotide binding-
protein-like 2 (Gnl2) and Gnl3/NS. We demonstrate that these proteins are required for correct timing of cell
cycle exit and subsequent neural differentiation in the brain and retina. Concomitantly, we observe aberrant
expression of the cell cycle regulators cyclinD1 and p57kip2. Our models demonstrate that the loss of Gnl2 or
NS induces p53 stabilization and p53-mediated apoptosis. However, the retinal differentiation defects are
independent of p53 activation. Furthermore, this work demonstrates that Gnl2 and NS have both non-cell
autonomously and cell-autonomous function in correct timing of cell cycle exit and neural differentiation.
Finally, the data suggest that Gnl2 and NS affect cell cycle exit of neural progenitors by regulating the
expression of cell cycle regulators independently of p53.),
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During development, induction and progression of neuronal
differentiation is a tightly regulated process that requires coordinated
regulation of proliferation, cell cycle exit and cell fate decisions. In the
developing vertebrate retina, six neuronal cell types (ganglion,
amacrine, horizontal, bipolar, cone and rod photoreceptors) and one
glial cell (Müller glia) type develop sequentially from a pool of
apparently homogeneous multipotent precursors (reviewed by
Harada et al., 2007). These particular cell types, their histology and
anatomy, as well as the underlying circuitry of the eye are highly
conserved in vertebrate species.
Gnl3/Nucleostemin (NS) was discovered as a nucleolar GTPase
that is highly expressed in stem cells, cancer cells and other actively
proliferating cells (Ma and Pederson, 2008; Tsai and McKay, 2002;
Tsai and Meng, 2009). It belongs to a subfamily of YlqF/YawG GTPasesthat are characterized by a MMR1_HSR1 GTP-binding domain
containing ﬁve circularly permutated GTP-binding motifs (Reynaud
et al., 2005). Among members of the eukaryotic family of YlqF/YawG
GTPases NS, Gnl3-like (Gnl3l), and Gnl2 (also known as NGP-1) are
the most related (Reynaud et al., 2005; Tsai and Meng, 2009).
Depending on their GTP-binding state, they shuttle between the
nucleolus and the nucleoplasm, although their predominant localiza-
tion is in the nucleolus (Meng et al., 2007; Tsai and McKay, 2005).
Gnl2, which shares approximately 33% protein sequence homology
with NS in humans, was initially identiﬁed as an immunoreactive
autoantigen isolated from a breast tumor library (Racevskis et al.,
1996). Similar to NS, Gnl2 shuttles between the nucleolus and the
nucleoplasm (Meng et al., 2007). However, further functional
characterizations of Gnl2 in vertebrates remain incomplete.
To date, vertebrate studies of NS have been limited to the
observation that Ns−/− murine embryos are arrested at blastocyst
stage due to a block in cell proliferation (Beekman et al., 2006; Zhu et
al., 2006). NS has been shown to bind directly to the tumor suppressor
p53 protein and depletion of NS results in p53 stabilization (Dai et al.,
2008; Meng et al., 2008; Tsai and McKay, 2002). Under normal
physiological conditions, p53 levels are kept low through the binding
to the E3 ubiquitin ligase Mdm2. Under stress conditions induced by
DNA damage, hypoxia, or oncogenic stress, Mdm2-mediated degra-
dation of p53 is inhibited by the phosphorylation of p53 and
decoupling from Mdm2 (Horn and Vousden, 2007). Stabilized p53
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target genes, including cell cycle inhibitors such as p21 (Riley et al.,
2008). In vitro as well as in vivo knockdown of NS causes G1-S phase
arrest and reduced cell proliferation (Beekman et al., 2006; Dai et al.,
2008;Ma and Pederson, 2007; Tsai andMcKay, 2002; Zhu et al., 2006).
Additional in vitro knockdown of p53 reversed the reduction in
cycling cells, showing that the cell cycle arrest is p53-dependent (Ma
and Pederson, 2007). The p53-mediated G1 cell cycle arrest was
proposed to result from enhanced binding of the ribosomal proteins
rpL5 and rpL11 that are released from the nucleolus to Mdm2 in the
cytoplasm (Dai et al., 2008). Recent studies have shown that in
addition to G1-S phase arrest, NS knockdown also causes G2-M phase
arrest in vitro that might also be p53-dependent (Meng et al., 2008;
Zhu et al., 2006).
Initially, it was shown that overexpression of NS causes p53
stabilization by direct binding and inhibition of Mdm2 (Dai et al.,
2008). Recent data, however, have shown that NS overexpression and
forced relocalization of NS to the nucleoplasm results in stabilization of
Mdm2 by inhibition of its degradation, which would subsequently
inhibit p53 activity (Meng et al., 2008). These ﬁndings suggest a role for
NS in controlling p53 activity in situations where NSwould be localized
in the nucleoplasm, such as upon nucleolar stress and during mitosis.
Several data suggest that not all defects following NS depletion or
overexpression are linked to p53 activity. Additional depletion of
functional p53 in Ns−/− murine embryos did not rescue the lethal
phenotype caused by the loss of NS (Beekman et al., 2006). Also,
combined in vitro knockdown of the ribosomal proteins rpL5, rpL11
and NS caused only a partial rescue of proliferation, despite the fact
that p53 activity levels were returned to normal (Dai et al., 2008).
These data suggest that further mechanisms of cell cycle control by NS
remain to be elucidated.
Here, we analyze the consequences of zygotic-effect mutations in
gnl2 and ns on zebraﬁsh development. We demonstrate that Gnl2 and
NS function redundantly in retinal neurogenesis. Loss of Gnl2 or NS
causes retinal progenitor cells to fail induction of cell cycle exit on
time, which appears to be the result of aberrant expression of cell
cycle regulators. In addition, differentiation of all retinal neural cell
types is delayed and reduced. We show that the failure of gnl2 and ns
mutant retinal progenitors to differentiate is not due to p53-induced
cell cycle arrest. In addition, we show that the function of gnl2 and ns
in retinal neurogenesis have both non-cell autonomous and cell-
autonomous aspects. Altogether, our ﬁndings suggest a novel role of
these nucleolar GTPases in maintaining proper levels of cyclinD1 and
p57kip2 that are key regulators of cell cycle progression.
Material and methods
Zebraﬁsh embryos and ﬁsh maintenance
Zebraﬁsh embryos were raised and staged as previously described
(Westerﬁeld, 1995). The gnl2bw41c mutation was recovered in a
forward genetic screen, whereas the nshu3259 mutation was generated
in a reverse genetic screen using the TILLINGmethod (Wienholds and
Plasterk, 2004). All mutant embryos were genotyped by nested PCR,
followed by Taqa1 restriction and fragment length electrophoresis for
gnl2 and DNA sequencing for nsmutants, using the following primers:
PCR1 gnl2-1 5′-ggtgcctgtctgttaatcaag-3′, gnl2-4 5′-gcgcta tacacgcatt-
taac-3′; PCR2 gnl2-2 5′-ttacacatttgccacagacc-3′, gnl2-3 5′-tgcagcaaa-
gacattggtag-3′ and PCR1 ns-1 5′-taggt caacattgcccaac-3′, ns-4 5′-
gagagtatcaaacacatgcagag-3′; PCR2 ns-2 5′-tttctca ctattccaggttcg-3′,
ns-3 5′-tgttgagttcttggcatt tg-3′.
Plasmid construction
pCS2+MT-d-Gnl2 and pCS2+MT-d-Ns constructs were con-
structed as follows. Full-length 2.2 kb Gnl2 (NM_213224) and 1.6 kbNS (NM_001002297) cDNAs were obtained by reverse transcription
of 48 hpf WT zebraﬁsh embryo-derived total RNA isolated in Trizol
(Invitrogen, Carlsbad, CA), followed by PCR using Phusion proofread-
ing Taq polymerase (Finnzyme, Espoo, Finland) according to the
manufacturer's instructions. The primers used were: Gnl2-F 5′-ttgaat
tcaaagatgttaagg-3′, Gnl2-R 5′-aactcgagttatcgcttggctcgatt-3′ and Ns-F
5′-ttgaattcag acatgaagagaccgaagttgaag-3′, Ns-R 5′-aactcgagttaca-
caaagtctgtgtt-3′ that contained an EcoRI and XhoI restriction site,
respectively. Subsequently, the PCR product was cloned into the
EcoRI–XhoI sites of the pCS2+MT expression vector. All constructs
were veriﬁed by sequencing.Western blotting
Embryos were untreated or exposed to 25 Gy of γ-irradiation. Four
hours after irradiation embryos were lysed (5 embryos/sample) in
Triton X-100 sample buffer, run over a 10% SDS-PAGE gel, transferred
and blotted with a monoclonal anti-zebraﬁsh p53 antibody as
previously described (MacInnes et al., 2008) and actin antibody
(Santa Cruz; sc-1616-R).Microarray hybridization and analysis
As a control for embryo sorting efﬁciency with respect to
phenotype–genotype correspondence, half of the collected gnl2
mutant embryos were genotyped and the other half used for RNA
isolation. Of the test-sorted collected embryos, 92% were genotypi-
cally gnl2−/− mutants (n=75), with the remaining 8% consisting of
gnl2+/− siblings.
Total RNA was isolated from 40 gnl2 and 40 WT embryos at 22 hpf
using Trizol (Invitrogen) according to themanufacturer's instructions.
Subsequently, RNA quality was checked using capillary gel electro-
phoresis (BioAnalyzer, Agilent Technologies, Santa Clara, CA, USA).
cDNA was generated using the low RNA input linear ampliﬁcation kit
and labeled with Cy3 or Cy5-CTP (Perkin-Elmer, Waltham, MA, USA).
Upon puriﬁcation using an RNeasy column (Qiagen) and fragmenta-
tion, labeled cRNA was hybridized to the zebraﬁsh 22K 60-mer
oligonucleotide microarray (G2518A-001, Agilent) at 60 ºC for 17 h.
Subsequently, slides were scanned using a microarray slide scanner
(Agilent).
Two independent biological repeats starting from independent
total RNA isolations were performed. Genes with Fold-ChangeN1.5,
were selected and uploaded to Genetools (http://www.genetools.no)
for gene ontology analysis according to the Gene Ontology category
“biological process”. The microarray data have been deposited in the
National Center for Biotechnology Information's Gene Expression
Omnibus and are accessible through GEO Series accession number
GSE21134.BrdU and EdU labeling of embryos
Dechorionated embryos were incubated in 10 mM BrdU (Sigma) or
400 μM EdU (Invitrogen) in 15% DMSO in embryo medium on ice for
30 min. Embryos were washed in fresh embryo medium and cultured
for an additional 5 min before ﬁxation in 4% paraformaldehyde.Histology
For histological analysis, embryos were ﬁxed in 4% PFA in
phosphate buffer, dehydrated, embedded in plastic (Technovit), and
sectioned at 7 μm. Subsequently, sections were stained in 1% toluidine
blue for 1 min, mounted with Depex and coverslipped.
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In situ hybridizations and immunohistochemistry were performed
essentially as previously described (Diks et al., 2006). DIG-labeled
riboprobes were synthesized according to the manufacturer's in-
structions (Roche): ascl1a (Allende andWeinberg, 1994), ath5 (Masai
et al., 2000), irx1a (Cheng et al., 2001). gnl2 and ns probes were
synthesized by direct riboprobe synthesis using T3 RNA polymerase
on puriﬁed PCR products for gnl2 exon 13 and ns exons 10 to 15 that
were obtained using the following primers: Gnl2-exon13F 5′-
taatacgactcactataggAGGCGATGCTGGAAATG, Gnl2-exon13R 5′-aat-
taaccctcactaaagggGGAGAAGTGCTTTGACTTGG-3′ and Ns-exon10-15F
5′-taatacgactcactataggCAACAGTGCAATCAGCAG-3′, Ns-exon10-15R
5′-aattaaccctcactaaagggGTCAGGTCAGTGTTGACTGG-3′. Probes to
ccnd1 (NM_131025) and p57kip2/cdkn1c (NM_001002040) were
synthesized on PCR products using the following primers: Ccnd1-
exon1/2F 5′-taatacgactcactatagg GACTCGAGCTCCAGCTTTC-3′, Ccnd1-
exon1/2R 5′-aattaaccctcactaaagggAGGAA GTTGGTGAGGTTCTG-3′,
and Cdkn1c-exon1F 5′-taatacgactcactataggAA ACAAACGTCGGCT-
CAC-3′, Cdkn1c-exon1R 5′-aattaaccctcactaaagggGAGGACT GAAGAAC-
GAGCTG-3′. As a template for PCR, cDNAwas synthesized from 48 hpf
zebraﬁsh embryo-derived total RNA. All PCR products were veriﬁed
by sequencing. Antibodies used were rat anti-BrdU (Sigma, 1:200),
rabbit anti-PH3 (Upstate Biotechnology, Lake Placid, USA; 1:200),
mouse anti-zn8 (ZIRC, 1:50), mouse anti-zrf1 (ZIRC, 1:1000), mouse
anti-zpr1 (ZIRC, 1:10), mouse anti-glutamine synthase (Millipore,
1:2000), α-HuC/D (Molecular Probes, 1:200), followed by a Cy3-
conjugated secondary antibody (Jackson ImmunoResearch, Suffolk,
UK). For BrdU/PH3 double immunoﬂuorescence, cryosections were
prepared as follows: ﬁxed embryos were incubated sequentially in 5
and 30% sucrose in PBS, followed by embedding and freezing in OCT
medium (Sakura), and cryosectioning at 10 μm. Sections were
permeabilized for 2 h in 100% methanol in −20 °C followed by a
30 min incubation in 0.2% Triton-X100 in PBS and a 30 min incubation
in 2 N HCl to denaturate DNA. Before incubation in antibodies,
sections were blocked for 1 h in 2% normal goat serum, 1% BSA, 1%
DMSO in PBS. For EdU/Zn8 double immunoﬂuorescence, embryos
were permeabilized using proteinase K (Sigma), incubated in EdU
detection mix (Click-iT EdU Alexa647 imaging kit,Invitrogen) for 1 h
according to the manufacturer's instructions and washed with 3% BSA
in PBS. Subsequently, embryos were processed for zn8 immunoﬂu-
orescence. TUNEL assays were performed as described previously
using TdT polymerase (Promega) and DIG-UTP (Roche) (Diks et al.,
2006).
Microinjections
A translation-blocking morpholino oligonucleotide was designed
to the ATG region of gnl2 (5′-TCCCCTTGAATTTTGCCTTAACCAT-3′;
Gene Tools, Philomath, OR) and 0.5 to 10 ng was injected into one-cell
stage embryos using pulled glass micropipettes. One nanogram of p53
morpholino oligonucleotide (5′-GCGCCATTGCTTTGCAAGAATTG-3′;
(Langheinrich et al., 2002)] Gene Tools, Philomath, OR) was injected
into one-cell stage embryos. Capped mRNAs were synthesized using
the mMESSAGE mMACHINE kit (Ambion). WT gnl2 and nsmRNA was
injected in a range of 400 to 500 pg into one-cell stage embryos.
Mosaic analysis
One-cell donor embryos were injected with 25 mg/ml mini-
emerald (lysine-ﬁxable dextran-ﬂuorescein and -biotin 10,000MW,
D7178, Invitrogen). Ten to ﬁfty cells of sphere-stage embryos were
transplanted into the prospective eye ﬁeld of shield-stage host
embryos using an oil-ﬁlled pulled glass capillary connected to a
micro-injector (Cell-Tram Vario, Eppendorf). Transplanted embryos
were examined for location of transplanted cells and exposed to a 30-minute EdU pulse at 48 hpf and ﬁxed. Transplanted cells were
visualized by incubating embryos in streptavidin conjugated to
Alexa488 (1:250, Invitrogen).
Imaging
In situ images were obtained using a Zeiss Axioplan Stereomicro-
scope (Oberkochen, Germany) equipped with a Leica (Wetzlar,
Germany) digital camera. Fluorescent labelings were imaged using a
Leica TCS SPE confocal microscope using 20× or 40× magniﬁcation or
an Olympus Fluoview FV1000 using 20× magniﬁcation. Images were
adjusted for brightness and contrast using Adobe PhotoshopCS2.
Quantiﬁcations
For analysis of retinal cryosections, cell numbers were quantiﬁed
using ImageJ software (NIH) on two sections of the central retina of
each animal using DAPI as a nuclear counterstain to determine total
retinal cell number. For analysis of the transplantations, raw confocal
stacks were imported into ImageJ and for each z-plane (z-step 2 μm),
DAPI-stained nuclei, ﬂuorescein+, EdU+ and Zn8+ cells were
marked using the manual cell counter plug-in, taking care not to
include duplications of same cells. Subsequently, the total number of
each marked cell type was exported to Microsoft Excel to analyze the
proportion of each cell type/transplanted clone. For analysis of the
EdU distribution, clones of transplanted cells were divided into 6
equidistant bins along the apico-basal axis of the clone/retina.
Subsequently, the number of EdU+ cells was determined for each
bin. For EdU intensity analysis, raw confocal stacks were imported
into ImageJ and a line drawn perpendicular to the apico-basal axis of
the transplanted clone and immediate surroundings. Next, a plot
proﬁle was created for gray values along the line for EdU and
ﬂuorescein.
Statistics
For each experiment, the chosen method of statistical analysis
and resulting p-values are stated in the text. Two-tailed Student's t-tests
assuming signiﬁcance levels ofα=0.05 were performed using Microsoft
Excel software; two-tailed Fisher's exact probability tests for a table of
frequency data were performed online (http://faculty.vassar.edu).
Results
A mutation in gnl2 causes unscheduled neuronal differentiation in the
zebraﬁsh embryo
The bw41c zebraﬁsh mutant was recovered in a forward
mutagenesis screen (D.Z., unpublished data) as aberrant in early
neuronal differentiation from 24 h post-fertilization (hpf). Expression
of the basic helix–loop–helix (bHLH) transcription factor achaete-
scute complex-like 1a (ascl1a; Figs. 1A–F) and other proneural genes
(data not shown)was expanded. This was accompanied by premature
terminal neuronal differentiation as visualized by the early post-
mitotic neuronal marker HuC/D at 36 hpf (Figs. 1G and H).
Morphologically, bw41c mutants were distinguishable from wild-
type (WT) embryos from 22 hpf by a reduced forebrain, expanded
hypophysis, smaller eyes, a thinner mid/hindbrain boundary
(MHB) and a hyperinﬂated hindbrain ventricle (Figs. 1I–L). At later
stages, the bw41c mutant embryos showed a shorter and more
curved body (Suppl. Fig. 1L). Homozygous embryos die around 5 days
post-fertilization (dpf), whereas heterozygous embryos develop
normally.
To identify the mutated gene, genetic mapping using chromosome-
speciﬁc sequence length polymorphisms (SSLPs) and single nucleotide
polymorphism (SNPs) (Guryev et al., 2006) was used to narrow
Fig. 1. Identiﬁcation of a loss of function mutation in zebraﬁsh gnl2. (A–F) Expression of the proneural bHLH transcription factor ascl1a is subtly expanded in the bw41cmutant (B)
diencephalon (arrow) and hindbrain (arrowhead) at 24 hpf. At 30 hpf, the ascl1a-expressing domain is expanded in the bw41cmutant hindbrain (arrowhead in D). At 42 hpf, ascl1a
expression is expanded in the midbrain (arrow), dorsal diencephalon and hindbrain (arrowhead) of bw41cmutants (F). (G and H) At 36 hpf, neuronal clusters were expanded in the
bw41c mutant brain as demonstrated by the terminally differentiated neuronal marker HuC/D. (I–L) bw41c mutant phenotype at 24 (J) and 48 hpf (L). The earliest clearly visible
defects in bw41cmutants (J) are the reduced forebrain (arrow), smaller eyes, thinner mid/hindbrain boundary (dashed line and arrowhead) and hyperinﬂated hindbrain ventricle.
At 48 hpf, bw41cmutants (L) are characterized by smaller eyes, thinner mid/hindbrain boundary (dashed line and arrowhead) and severe hyperinﬂation of the hindbrain ventricle.
(M) Schematic drawing of the Gnl2 protein with the bw41cmutation indicated by the dashed red line. (N) Phylogenetic tree of the ﬁve members of the Gnl family, Lsg-1, Gnl1, Gnl2,
Gnl3/NS and Gnl3l in Drosophila melanogaster (dm), Danio rerio (dr), Mus musculus (mm) and Homo sapiens (hs). Lsg1 and Gnl1 on one hand, and Gnl2, Gnl3/NS and Gnl3l on the
other hand appear to have separate common ancestors. In Drosophila and other invertebrates, there are no separate orthologs of Gnl3/NS and Gnl3l, but one common ortholog that is
more similar to NS than to Gnl3l. All images are lateral view, with anterior to the left and dorsal up. di, diencephalon; e, eye; h, hindbrain; hv, hindbrain ventricle; ot, optic tectum; tg,
tegmentum; t, telencephalon. Scalebar 125 μm.
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(Suppl. Fig. 1A). Sequencing of seven genes present in this region
identiﬁed a cytosine to thymine mutation introducing a premature
stop codon in exon 3 of guanine nucleotide binding protein-like 2
(gnl2; Suppl. Fig. 1B), corresponding to an arginine in position 53
within the ﬁrst basic domain of the zebraﬁsh Gnl2 protein (Fig. 1M).
Gnl2 is a member of a family of evolutionary conserved circularly
permutated GTPases, among which Gnl3/Nucleostemin is the best
known (Fig. 1N) (Ma and Pederson, 2008; Tsai and Meng, 2009).Since the bw41c mutation is located early in the protein and N-
terminal to the GTP-binding sites (Fig. 1M), themutation is predicted
to result in a loss of function of Gnl2.
To conﬁrm that the bw41c mutation leads to Gnl2 loss of
function, we utilized a translation-blocking ATG-morpholino (MO)
speciﬁc to the gnl2 sequence. Indeed, injection of 2 to 10 ng of gnl2
MO into WT embryos phenocopied the bw41c mutant phenotype
(Suppl. Figs. 1D–K) as it resulted in expanded expression of
proneural genes similar to the bw41c mutant.
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only 30% of injected gnl2+/+ siblings (n=10), severely exacerbated
the bw41c phenotype in 82% of the injected gnl2−/− embryos (n=11)
and induced a bw41c-like phenotype in 53% of the injected gnl2+/−
siblings (n=17; data not shown). To further conﬁrm that disruption
of gnl2 underlies the bw41c phenotype, WT gnl2 mRNA was injected
into progeny of gnl2+/− carriers. Injection of WT gnl2mRNA partially
rescued the smaller eye and body size of gnl2mutants (Suppl. Fig. 1N).
Injection of higher doses (N475 pg) ofWT gnl2mRNA inWTs or bw41c
mutants resulted in lethality. These data led us to conclude that Gnl2
loss of function is indeed the cause of the bw41c phenotype. The
bw41c/gnl2 mutant may be viewed as a hypomorph due to the
presence of maternal mRNA and/or protein that masks potential
earlier phenotypes.A mutation of gnl3/nucleostemin results in phenotypes similar to the loss
of gnl2
To understandmore about the potentially important role of NS and
related proteins such as Gnl2 in embryonic development, we set out
to compare the NS loss of function phenotype in developing zebraﬁsh
with that of Gnl2. To achieve this, we employed the TILLING
(Targeting Induced Local Lesions IN Genomes) method (Wienholds
and Plasterk, 2004) to generate a nonsense mutation in the ns gene.
We identiﬁed a nonsense mutant allele, nshu3259, which contained a
premature stop codon in exon 5 of the zebraﬁsh ns gene correspond-
ing to a glutamic acid in position 117 (Suppl. Fig. 1C). The resulting
phenotype (Figs. 2A–D) is reminiscent of the phenotype observed in
the ns/gnl3hi299Tg mutant allele generated by an independent viral
integration screen (Amsterdam et al., 1999). This similarity and the
fact that the ns mutation resides N-terminal to the GTP-binding
domains of NS (Fig. 2E) suggest that the nsmutation represents an NS
loss of function.
Similar to the gnl2mutant, homozygous nsmutants were morpho-
logically distinct from WT siblings around 22 hpf and were character-
ized by a reduced forebrain, expanded epiphysis, reduced MHB and
hyperinﬂated hindbrain ventricle (Figs. 2A and B). At later stages, ns
mutants were generally smaller than their WT siblings, including
smaller eyes andheads, although the body curvature, size reduction and
age of lethality were all the more severe in the gnl2 mutants (Figs. 2C
and D, Suppl. Fig. 1M). Heterozygous ns embryos were phenotypically
normal. To conﬁrm that the ns phenotype is speciﬁcally due to a loss of
NS,WTnsmRNAwas injected into theprogenyofns+/−ﬁsh. Injection of
500 pgWT nsmRNA, but not of lower concentrations, partially rescuedFig. 2. A loss of function mutation in zebraﬁsh ns indicates redundancy between Gnl2
and NS. (A–D) The earliest visible defects that emerge around 24 hpf (A and B) in ns
mutants (B) are the reduced forebrain (arrow), reduced eye size, thinner mid/
hindbrain boundary (dashed line and arrowhead) and hyperinﬂated hindbrain
ventricle. At 48 hpf, ns mutants (D) are characterized by smaller eyes, thinner mid/
hindbrain boundary (dashed line and arrowhead) and severe hyperinﬂation of the
hindbrain ventricle. (E) Schematic drawing of the NS protein with the position of the
nshu3259 mutation indicated by the red dashed line. (F and G) gnl2 transcript is
expressed throughout the brain at 30 hpf (F), with higher expression levels in the
dorsal diencephalon, optic tectum, hindbrain and retina (inset in F). At 48 hpf (G), gnl2
transcript is expressed in the proliferative areas of the brain, namely the dorsal
diencephalon, posterior optic tectum and hindbrain. In the retina, gnl2 expression is
restricted to the proliferative ciliary marginal zone at 48 hpf (inset in G). ns transcript is
expressed throughout the brain at 30 hpf (H), with higher expression levels in the
dorsal diencephalon, optic tectum, hindbrain and retina (inset in H). At 48 hpf, ns
transcripts are expressed in the dorsal diencephalon, posterior optic tectum and
hindbrain (I). In the retina, ns is expressed in the ciliary marginal zone (inset in I). (J–M)
The morphology of WT (J), single ns (K), single gnl2 (L) and gnl2/ns compound mutants
(M) shows synergistic worsening of the mutant phenotypes, such as reduction of the
telencephalon (arrows) and eye size, upon combined depletion of gnl2 and ns. All
images are lateral view, with anterior to the left and dorsal up. d, dorsal diencephalon;
e, eye; h, hindbrain; hv, hindbrain ventricle; ot, optic tectum. Scalebar 125 μm.the embryo size, including eye size (Suppl. Fig. 1O). Injection of higher
doses of nsmRNA caused lethality.
Gnl2 and NS have (partially) redundant functions
We examined gnl2 and ns expression throughout development
and found both genes to be expressed throughout the WT embryo,
with high levels of expression in proliferating areas of the brain and
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expression was restricted to the remaining proliferating zones of
the brain, consisting of the posterior tectum, hindbrain and dorsal
diencephalon (Fig. 2G), and to the ciliary marginal zone (CMZ) of
the retina that retains proliferative activity in adult ﬁsh (Raymond
et al., 2006; Wullimann and Knipp, 2000). In gnl2 mutants,
expression of gnl2 was decreased at 30 hpf, suggesting nonsense-
mediated decay of the mutant transcript (data not shown). High
levels of ns mRNA expression was observed in regions of
proliferative activity such as the optic tectum, retina and hindbrain,
although in general ns expression was more restricted than that of
gnl2 (Figs. 2H and I). At 48 hpf, nswas expressed in the optic tectum,
dorsal tel- and diencephalon, hindbrain and in the retinal CMZ
(Fig. 2I). In nsmutants, ns transcripts were decreased at 30 hpf (data
not shown), suggesting nonsense-mediated decay of the ns mutant
transcript as well.
Although we do not know the expression proﬁles of Gnl2 and NS
proteins in the zebraﬁsh, the similar expression patterns of gnl2 and
ns mRNAs in combination with their similar morphological pheno-
types suggest that Gnl2 and NS may function redundantly.
To investigate this, gnl2/ns compound heterozygous carriers
were generated and the phenotypes of their progeny were
examined. Prior to 36 hpf, compound gnl2/ns homozygous mutants
did not appear signiﬁcantly different from the gnl2mutant (data not
shown). From 36 hpf onwards, double mutants were apparent by a
synergistic phenotype resulting in a further reduction of eye size
and a more severe hyperinﬂation of the hindbrain ventricle
(Figs. 2J–M; Suppl. Figs. 2A and B). At 72 hpf, the body length,
head size, and eye size of the compound mutants were dramatically
reduced compared to the WT, gnl2, or ns single mutant siblings
(Suppl. Figs. 2B and C). These synergistic phenotypes suggest that
gnl2 and ns indeed function at least in part redundantly. To further
test redundancy of Gnl2 and NS, we investigated whether
misexpression of WT gnl2 or ns mRNA was able to improve the ns
and gnl2 mutant phenotypes, respectively. Indeed, injection of
475 pg of WT gnl2 mRNA was able to partially restore head and eye
size of nsmutants (Suppl. Fig. 2D). Conversely, injection of 500 pg of
WT ns mRNA into gnl2 mutants resulted in a similar partial rescue
(Suppl. Fig. 2D), indicating that gnl2 and ns are able to compensate
at least partially for the loss of the other gene.Loss of NS and/or Gnl2 causes delayed differentiation of retinal
progenitors
The decrease of expression levels of gnl2 and ns during
development appears to be correlated with decreased proliferation
rates as development proceeds. In addition, the domains that retain
high levels of gnl2 and ns expression represent regions that are known
to maintain their proliferative capacity in postembryonic stages.
These facts are highly suggestive of a function of gnl2 and ns in
maintaining populations of neural progenitors.
The zebraﬁsh retina is easily accessible for analysis of cell fate
acquisition as it consists of a highly ordered structure containing a
limited number of neuronal cell types (Stenkamp, 2007). Thus, we
elected to analyze retinal neurogenesis in gnl2, ns, and gnl2/ns double
mutants to further investigate the effects of gnl2 and ns depletion on
proliferation and differentiation.
Histological sections reveal incomplete formation of the retinal
ganglion cell layer (GCL) and inner and outer nuclear layers (INL,
ONL) of the retina in gnl2 and nsmutants at 72 hpf as compared toWT
embryos (Figs. 3A–C). The total number of nuclei in the gnl2 and ns
mutants as compared to WTs was slightly reduced at 30 hpf (data not
shown) and was about two-fold reduced at 48 hpf (554±59 cells in
WT retina (n=6), 284±18 cells in gnl2 (n=3) and 274±52 cells in
ns (n=3; Student's t-test, pb0.01). However, retinal development ingeneral was not delayed, as pigment formation occurred normally and
on time (data not shown).
We next investigated the differentiation of retinal neuronal and
glial cell types in the gnl2 and ns mutants. In WT zebraﬁsh embryos
prior to 28 hpf, all neural retina precursors are proliferating.
Expression of the bHLH transcription factor ath5 marks retinal
progenitors preceding their ﬁnal cell cycle exit and is ﬁrst induced
in the ventronasal retina (Kay et al., 2001, 2005). Subsequently, its
expression progresses through the retina, preceding the wave of
retinal ganglion cell (RGC) differentiation (Fig. 3D). In gnl2 mutants
(Fig. 3E), only a few cells expressing ath5were present in the retina at
36 hpf, contrasting in contrast with its broad expression inWT retinae
(Fig. 3D). In contrast, ath5 expression in ns mutants was relatively
normal at 36 hpf (Fig. 3F). At 48 hpf, ath5 expression was present
throughout the prospective RGC layer in gnl2 and ns mutants, similar
to ath5 expression in WTs (data not shown).
Immunolabeling with zn8, an antibody that labels mature RGCs
(Figs. 3G and J), showed a delay in RGC differentiation at 48 hpf in gnl2
(Fig. 3H) and ns mutants (Fig. 3I). At 72 hpf, the GCL in gnl2 mutants
remained poorly differentiated with RGCs being localized only in the
central retina directly behind the lens (Fig. 3K). Unlike gnl2 mutants,
the GCL was regularly shaped in ns mutants at 72 hpf. However,
similar to gnl2, the GCL failed to extend around the lens completely
(Fig. 3L). In gnl2/ns compoundmutants, differentiated RGCs were only
present in a small portion of the central retina, showing a synergistic
effect of the loss of Gnl2 and NS on RGC differentiation (Fig. 3V). The
delay in RGC differentiation in gnl2 and nsmutants was conﬁrmed by
delayed and reduced expression of irx1a, a marker for early
differentiated RGCs (data not shown).
Differentiation of amacrine cells in the zebraﬁsh inner nuclear
layer (INL) starts around 35 hpf (Fig. 3M). Amacrine cells were
reduced in gnl2 (Fig. 3N) and ns mutants (Fig. 3O) at 48 hpf as
observed using HuC/D labeling, which labels RGCs and amacrine cells.
Photoreceptor cells start to differentiate in the zebraﬁsh outer nuclear
layer (ONL) around 43 hpf (Fig. 3P). In gnl2 mutants, cone
photoreceptor cells as labeled with zpr1 were present only in the
central retina (Fig. 3Q). In ns mutants, cone photoreceptor cells were
present almost throughout the ONL, indicating their normal differen-
tiation (Fig. 3R). In gnl2/ns compoundmutants, no cone photoreceptor
cells were observed (Fig. 3W).
The last cell type in the zebraﬁsh retina that initiates terminal
differentiation around 48 hpf is the Müller glial cell, which has its
soma located in the INL and its processes extending towards the basal
and apical surfaces (Fig. 3S). Using the zrf1 antibody (α-GFAP) that
labels Müller glial cells, we observed a marked reduction of Müller
glial somata and their processes in gnl2mutants (Fig. 3T). In addition,
there was an ectopic expression of zrf1 in the inner limiting
membrane that separates the retina and vitreous body, which
suggests a defect in the Müller endfeet that terminate here. When
we examined the gnl2 retina using an antibody to glutamine synthase,
another marker of glial cells, we observed abnormal distribution of
Müller glial somata in the INL of gnl2 mutants (Suppl. Fig. 3). In
addition, there were glial cells expressing high levels of glutamine
synthase immediately surrounding the optic nerve, with their apical
endfeet ending at the inner limiting membrane. These cells could be
reactive astrocytes or premature reticular astrocytes that develop
from optic stalk cells (Maggs and Scholes, 1990). In contrast to gnl2,
Müller glial cells were present in the ns mutant GCL in a relatively
normal pattern (Fig. 3U). In compound gnl2/ns mutants, Müller glial
cells were almost entirely absent (Fig. 3X).
Taken together, these data show that the impaired RGC differen-
tiation due to loss of gnl2 or ns is not accompanied by adoption of
alternate later retinal cell fates by the precursors. In addition, the data
show that the timing of neuronal and glial differentiation is affected
more severely in gnl2mutants than in nsmutants. The combined loss
of gnl2 and ns causes evenmore severe delays in differentiation up to a
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Fig. 4. Upon Gnl2 and NS loss of function, retinal progenitors fail to exit the cell cycle in a timely manner. (A–J). Confocal images of BrdU (green) and PH3 (red) double
immunolabelling with DAPI overlay (blue) in WT (A, D and G), gnl2 (B, E, H) and ns (C, F and I) embryos at 48 hpf. Retinae are outlined with dashed lines and subdivided into the
peripheral (white arrowheads) and central retinae (yellow arrowhead) by dotted lines. In gnl2 (B) and ns (C) embryos at 48 hpf, many BrdU+ cells are present throughout the
central retina (yellow arrowheads), whereas in the WT, BrdU+ cells are mainly found at the retinal margin (white arrowheads). The number of PH3+ cells is slightly decreased in
gnl2 mutants (E), but not in ns mutants (F). (J) Quantiﬁcation of the percentage of BrdU+ cells over the total cell number shows that there is no difference at 30 hpf. At 48 hpf,
signiﬁcantly more retinal cells are undergoing S-phase in gnl2 and nsmutants. (K) Quantiﬁcation of the percentage of PH3+ cells over total cell number shows a reduction in cells
undergoing M-phase in gnl2, but not in ns mutants. Lateral is up, anterior to the left. Statistics: Student's t-test. p-values and experimental numbers indicated in graph. Error bars
represent SD. Scalebar 25 μm.
293J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301point that the last retinal cell types to differentiate (photoreceptors
and Müller glia) are absent or drastically reduced.
Loss of gnl2 and ns results in aberrant expression of cell cycle markers
Delayed terminal neuronal differentiation of retinal precursor cells
may be due to the inability of precursors to exit the cell cycle. ToFig. 3. Delayed RGC differentiation in the gnl2 and nsmutant retina. (A–C) Transverse toluidin
GCL, INL and ONL at 72 hpf (arrowheads). Arrow indicates optic nerve head. (D–F) Expressio
from a few cells in gnl2mutants (E; n=7 embryos), whereas its expression is reduced, but i
lens. (G–L) Confocal images of immunolabelings to the RGC marker zn8 (red) with DAPI n
disorganized and reduced in width at both 48 hpf (H; n=11) and 72 hpf (K; n=25). In nsm
improved at 72 hpf (L; n=19). Insets show single zn8 ﬂuorescence views. Dashed circles in
the eye. (M–O) Single confocal planes of Hu/D (green) and zn8 (red) labeling with DAPI nu
RGCs only, respectively, in gnl2 (N; n=5) and ns mutants (O; n=6) at 48 hpf. Arrowhead s
boundary of GCL, dotted line marks boundary of amacrine cells in the INL. Insets show single
marked by zpr1 staining in red with DAPI nuclear counterstaining (blue) are present in the ce
mutants, photoreceptor cells have differentiated and are present throughout the outer nucle
glial cells, marked by zrf1 staining in redwith DAPI nuclear counterstaining (blue), have deve
gnl2mutants (arrowhead in T; n=9). Insets show single zrf1 ﬂuorescence views. (V–X) Diffe
(n=4; W, compare to P) and Müller glial cells (n=3; X, compare to S) is severely affected i
(A–C) Lateral up, anterior to the left. (D–L) Lateral view, anterior to the left and dorsal up. (
layer; le, lens; ONL, outer nuclear layer. Scalebar 25 μm.determine the proportion of retinal cells in S- and M-phase, we
analyzed BrdU-incorporation and cells expressing phosphorylated
histone 3 (PH3), respectively, at 30 and 48 hpf (Fig. 4). At 30 hpf,
many cells in the WT retina are proliferating as visualized by BrdU
labeling (Fig. 4J). In gnl2 and ns mutants, there was no difference at
30 hpf in the percentage of BrdU-positive cells/retina (Fig. 4J) as
compared toWTs. However, the percentage of PH3-positive cells/totale-blue stained sections ofWT (A), gnl2 (B) and ns (C) showing incomplete formation of
n of ath5marks retinal progenitors prior to cell cycle exit. At 36 hpf, ath5 is absent apart
s normally patterned in nsmutants (F; n=6). Dashed circle indicates the outline of the
uclear counterstaining (blue) at 48 (G–I) and 72 (J–L) hpf. In gnl2 mutants, the GCL is
utants, formation of the GCL layer is incomplete at 48 hpf (I; n=22), but has markedly
dicate the outline of the lens; the additional outer circle in (K) delineates the outline of
clear counterstaining (blue), which labels RGCs and differentiated amacrine cells, and
hows amacrine cells that are labeled with HuC/D, but not with zn8. Dashed line shows
HuC/D and zn8 ﬂuorescence views. (P–R) At 96 hpf, differentiated photoreceptor cells
ntral gnl2mutant retina only (boundaries indicated with arrowheads in Q; n=8). In ns
ar layer (R; n=5). Insets show single zpr1 ﬂuorescence views. (S–U) At 96 hpf, Müller
loped relatively normally in nsmutants (U; n=11), but are disorganized and reduced in
rentiation of retinal cell types, such as RGCs (n=5; V; compare to J), photoreceptor cells
n gnl2/ns compound mutants as compared to WTs. Inset show single ﬂuorescence view.
M–X) Dorsal view, with anterior to the left. GCL, ganglion cell layer; INL, inner nuclear
Fig. 5. Aberrant expression of cell cycle regulators in gnl2 and ns mutant retinae. (A–F) Transverse sections showing expression of ccnd1 at 36 hpf (A–C) and 48 hpf (D–F). In theWT
retina, a subset of cells has downregulated ccnd1 (arrowheads in A), indicating their withdrawal from the cell cycle. At 48 hpf, ccnd1 is restricted to the ciliary marginal zone that
remains proliferative (arrowheads in D). In contrast, ccnd1 is not downregulated in gnl2 (n=10; B) or ns (n=10; C) mutant retinae at 36 hpf (arrowheads) and remains expressed
in the central retina of gnl2 mutants (n=9; arrow in E). In ns mutants, ccnd1 expression is downregulated in the central retina (n=9; arrow in F), but remains expressed in the
remainder of the retina (arrowheads). (G–L) Sections showing expression of p57kip2 in the WT central retina at 36 hpf (arrow in G). In contrast, there is no expression in gnl2
(n=11; H) and ns (n=9; I) mutant retinae (arrows). At 48 hpf, p57kip2 expression is restricted to the lateral surface of the retina in WTs (arrowheads in J). In contrast, p57kip2 is
expressed in the central retina of gnl2, (n=12; arrow in K) and nsmutants (n=13; arrows in L). Dashed lines indicate outline of the retina. Dorsal view, anterior to the left. le, lens.
Scalebar 25 μm.
294 J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301number of retinal cells was signiﬁcantly reduced in gnl2 mutants at
30 hpf (Fig. 4K). At 48 hpf, most cells in the central WT retina have
exited the cell cycle as they no longer incorporate BrdU (Fig. 4A). In
contrast, many cells in the central retina of gnl2 and ns mutants are
still BrdU-positive (Figs. 4B, C and J). Intriguingly, the percentages of
PH3-positive cells in the whole retina of gnl2 and nsmutants were not
similarly increased (Figs. 4D–F and K). Thus, loss of Gnl2 and NS (to a
lesser degree) causes a relative decrease in the number of cells in M-
phase as opposed to the number of cells in S-phase (Fig. 4K).
The cell cycle regulator Cyclin D1 (Ccnd1) promotes proliferation,
whereas p57Kip2 (also known as Cdkn1c) inhibits G1-S-phase
transition by inhibiting PCNA-mediated DNA replication (WatanabeFig. 6. p53 stabilization upon loss of Gnl2 and NS causes apoptosis and differentially affects re
p53 protein in gnl2 and nsmutants at 48 hpf (left and middle panel) and nsmutants at 96 h
stabilization of p53 upon exposure to 25 Gy of γ-irradiation is shown. Irradiation of gnl2 and
the bottom panel. (B–G) Tunel assay showing presence of apoptotic cells in gnl2 (C; n=6) a
mutants, apoptosis was less pronounced as compared to gnl2mutants. (E–G) Upon injection
(G; n=16). Injection of p53 MO has no effect on cell survival in WT embryos (E; n=57). (
RGCs, with DAPI nuclear counterstaining (blue). (K–M) and (Q–S) show single zn8 ﬂuoresce
single p53mutants (n=4; N and Q) has extended around the lens in a cup-like shape (arrow
formed GCL (arrows in L andM) and RGCs are present only in the central retina. In gnl2/p53 c
retina and failed to extend around the lens (arrows in R) similar to single gnl2mutants (arrow
mutants (arrowheads in L and R). Similarly, the GCL in ns/p53 compoundmutants (n=5; P a
nerve is similar to that of single nsmutants (arrowheads in M and S). (B–J and N–P) Lateral
diencephalon; h, hindbrain; ot, optic tectum; t, telencephalon; uic, uninjected control. Scalet al., 1998) as well as by inhibiting cyclinD–CDK4/6 complexes
(Besson et al., 2008). In the zebraﬁsh retina, forced expression of
p57kip2 induces cell cycle exit of retinal progenitors (Shkumatava and
Neumann, 2005). In WT retinae, ccnd1 expression is present
throughout the retina at 36 hpf and progressively restricted during
retinal neurogenesis to only the CMZ at 48 hpf (Figs. 5A and D). In gnl2
and ns mutants, ccnd1 failed to be timely downregulated and
remained expressed in the central retina at 48 hpf (Figs. 5B, C, E and
F), indicating that more retinal precursors in themutants continued to
cycle. Conversely, expression of the CDK inhibitor p57kip2was absent
in the gnl2 and ns retina at 36 hpf (Figs. 5H and I), whereas it was
expressed in the central WT retina (Fig. 5G). At 48 hpf, p57kip2 wastinal differentiation. (A) Western blot analysis of p53 (top panel) shows stabilization of
pf (right panel) in comparison to low levels of p53 protein in WT embryos. As a control,
nsmutants does not visibly increase p53 levels. The loading control for actin is shown in
nd nsmutants (D; n=6) at 48 hpf with the highest incidence in the optic tectum. In ns
of 1 ng of p53 MO, apoptosis is dramatically reduced in gnl2 (F; n=13) and nsmutants
H–S) Confocal views of immunolabeling with zn8 antibody (green) that marks mature
nce. Dashed lines indicate the outline of the lens. At 72 hpf, the GCL inWT (H and K) and
s in K and Q). In contrast, gnl2 (n=5; I and L) and ns (n=5; J andM)mutants lack a fully
ompoundmutants (n=3; O and R), differentiated RGCs were present only in the central
s in L). The optic nerve size was equivalent between single gnl2 and compound gnl2/p53
nd S) fails to extend around the lens properly (arrows in S) and the diameter of the optic
view, anterior to the left, dorsal up. (K–M and Q–S) Dorsal view, anterior to the left. di,
ebar (B–G) 125 μm, (H–P) 25 μm.
295J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301expressed only in the CMZ in WTs (Fig. 5J), whereas it was present in
the central retina of gnl2 and nsmutant (Figs. 5K and L), suggesting a
delayed onset of p57kip2 expression in mutant retinae.
The above data show that in the gnl2 and ns mutant retina,
precursors continue to express cell cycle regulators and show delayedexpression of cell cycle exit markers. These defects may cause the
observed delays in cell cycle exit and terminal neuronal differentia-
tion. Surprisingly, the loss of Gnl2 causes premature neuronal
differentiation in the developing brain (Figs. 1A–H). Similar to gnl2,
the expression domain of the proneural gene ascl1a was expanded in
296 J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301the nsmutant brain (data not shown). At 30 hpf, ccnd1 expressionwas
expanded in the gnl2 and ns brain (Suppl. Figs. 4A–C). Intriguingly, the
expression of p57kip2 was also expanded in the gnl2 and ns mutant
brain from 30 hpf (Suppl. Figs. 4D–F). These data suggest that in the
brain, premature cell cycle exit occurs in contrast to the retina where
late cell cycle exit occurs (Figs. 5L–Q). At 48 hpf, ccnd1 expression was
increased predominantly in the dorsal midbrain (Suppl. Figs. 4G–L).
At the same time, p57kip2 expression in the brain was reduced in the
gnl2 fore- and dorsal midbrain as compared to WTs but relatively
increased in ventral midbrain and diencephalon (Suppl. Figs. 4M–R).
These data suggest that the different effects of Gnl2 and NS loss of
function on neurogenesis in the brain and retina may be the
consequence of differential expression of the cell cycle inhibitor
p57kip2.
Gene expression changes upon loss of Gnl2
Because little is known about the function of Gnl2 in vertebrates,
we examined the gene expression proﬁle of gnl2 mutant versus WT
embryos using microarray analysis. The gene expression proﬁle was
examined at 22 hpf, which was the earliest development stage at
which the gnl2 mutant phenotype could be readily identiﬁed (Suppl.
Figs. 5A and B). Statistical analysis revealed 96 signiﬁcantly up- and 44
downregulated genes with an at least 1.5-fold change in expression
and a p-valueb0.05 (Suppl. Table 1). Of these genes, 64 up- and 26
downregulated genes had a known Gene Ontology (GO) biological
process function (Suppl. Fig. 5C).
Functional characterization of the downregulated genes showed
that about 30% of downregulated genes are regulators of transcription
(zbtb16, rdbp, vsx2, otp, pcid2, sox2, pias4) or genes encoding proteins
involved in ribosome biogenesis (rpl22l1, rps16, rpl30, gnl2). Further-
more, several pro-apoptotic and apoptosis-mediating genes (dedd1,
dap1b, gadd45gl, dnase1l3) were downregulated. In the upregulated
group of genes, many components of the p53-cell death pathway
were present (p53, bnip3, bax, vrk2, gadd45al, sesn3, casp8, ccng1).
Other upregulated genes involved in cell cycle arrest were h2afx and
cdkn1bl. Importantly, expression of mdm2, which is a direct target of
p53, was found to be upregulated. There was no change in expression
levels of ccnd1 or p57kip2 at this stage.
To conﬁrm the microarray results, in situ hybridizations were
performed for gnl2 and two direct transcriptional targets of p53,
mdm2 (Wu and Levine, 1997) and ccng1 (Okamoto and Beach, 1994).
In agreement with the microarray data, in situ hybridizations showed
reduction of gnl2 (Suppl. Figs. 5D and E) and induction of both mdm2
(Suppl. Figs. 5F and G) and ccng1 expression (Suppl. Figs. 5H and I) in
the gnl2 mutant brain at 22 hpf. Expression of these genes was
indistinguishable between WT and gnl2+/− embryos (data not
shown).
p53 activation causes apoptosis in gnl2 and ns mutants
The gnl2 expression proﬁle suggests that Gnl2 loss of function
causes p53 stabilization and activation. NS loss of function has
previously been shown to cause p53 activation in vitro (Ma and
Pederson, 2007; Meng et al., 2008; Tsai and McKay, 2002). WeFig. 7. Gnl2 acts non-cell autonomously in retinal cell cycle exit and differentiation. (A) Exper
with ﬂuorescein-dextran and biotin-dextran and are subsequently transplanted into the pro
30-minute EdU pulse at 48 hpf and were ﬁxed immediately. Clones were examined for th
images of clones of transplanted cells showing DAPI-counterstained nuclei (cyan, top left), s
(magenta, bottom right). Clones of transplanted cells are outlined by dotted lines (white or
fromWT donor to WT host (B), WT donor to gnl2mutant host (C), 2 ng gnl2MO-injected do
(F) Quantiﬁcation of the percentage of EdU+ (black bars) and zn8+ RGCs (striped bars)
Student's t-test, p-values indicated above the bars (*pb0.01, **pb0.02). Error bars represent
cells. The clones were divided along their baso-apical axis in 6 equidistant bins and the perce
and gnl2→WT and gnl2→gnl2 show similar distribution of EdU+ cells along the apico-ba
WT→WT and WT→gnl2 mutant, and gnl2→WT and gnl2→gnl2 clones. Statistics: Two-taileevaluated p53 stabilization in gnl2 and ns mutants by Western
blotting using a zebraﬁsh-speciﬁc monoclonal p53 antibody
(MacInnes et al., 2008). In gnl2 and ns mutant embryos at 48 hpf
and 96 hpf, respectively, p53 protein is found to be stabilized in the
absence of γ-irradiation, with no apparent increase in stabilization
observed upon the application of γ-irradiation (Fig. 6A). However, we
detected very little stabilization of p53 in the ns mutants at 48 hpf
(Fig. 6A). This suggests that the loss of both Gnl2 and NS in zebraﬁsh
embryos induces the stabilization of p53 and that the results are
consistent with the observation that the gnl2 mutant phenotype is
more severe than that of ns.
Since p53 activation can induce programmed cell death, we
examined the number of apoptotic cells in gnl2 and ns mutants using
TUNEL analysis. Indeed, more apoptotic cells were observed through-
out the brain of gnl2 and ns mutants at 30 hpf as compared to WTs
(data not shown). At 48 hpf, many apoptotic cells were present
throughout the gnl2 brain (Fig. 6C) and to a lesser extent in the ns
brain (Fig. 6D). To evaluate the contribution of p53 activation to the
gnl2 and ns apoptosis phenotypes, a p53 translation-blocking
morpholino was injected and apoptotic cells were evaluated at 30
(data not shown) and 48 hpf (Figs. 6E–G) by Tunel assay and Acridine
Orange labeling of apoptotic cells (data not shown). Injection of 1 ng
p53 MO, a concentration previously shown to rescue apoptosis
induced byMdm2 knockdown in zebraﬁsh (Langheinrich et al., 2002),
dramatically reduced apoptosis throughout the brain and retinas in
both mutants as visualized by Tunel (Figs. 6F and G). The contribution
of activated p53 to the apoptotic phenotype is reﬂected by the
ameliorated morphology of the gnl2 and ns mutant brains (data not
shown). However, the eye and head size of the MO-injected mutants
remained noticeably smaller in comparison to their WT siblings and
the lethality of the embryos remained the same as their non-injected
mutant cohorts.
p53 activation does not cause the delayed neuronal differentiation in the
gnl2 and ns retina
As knockdown of p53 does not appear to rescue the gnl2 and ns
mutants' lethal phenotype fully, we next investigated the p53-
dependence of the mutants' differentiation phenotypes and analyzed
RGC differentiation in gnl2 and ns mutants upon additional depletion
of p53. p53 was ablated either by injection of p53 MO or by crossing
gnl2 or ns mutants into a previously described zebraﬁsh tp53M214K/
M214K mutant loss of function line (Berghmans et al., 2005).
The ath5 and irx1a expression domains that indicate proneural and
early RGC fate, respectively, were absent in single gnl2 (n=8) and
compound gnl2/p53mutants (n=3) at 36 hpf (Figs. 3D and E and data
not shown). At 48 hpf, the irx1a expression domain did not
completely surround the lens in single gnl2 (n=6) and gnl2/p53
compound mutants (n=3; data not shown). Immunolabeling of
embryos with zn8 showed that differentiated RGCs were present only
in the central retina of gnl2 and gnl2/p53 compound mutants at 48
(data not shown; n=4) and 72 hpf (Figs. 6I, L, O and R), suggesting
that p53 reduction did not prevent the delay in RGC differentiation
caused by Gnl2 loss of function. Similar results were obtained by
injection of p53 MO into gnl2 mutants (Suppl. Figs. 6B, E and G). Inimental setup. Cells are taken from sphere-stage donor embryos that have been injected
spective eye ﬁeld of shield-stage unlabelled host embryos. Embryos were exposed to a
e proportion of EdU+ proliferating cells and zn8+ RGCs. (B–E) Single-plane confocal
treptavidin-Alexa488 (green, top right), EdU (white, bottom left) and zn8-stained RGCs
green). The retina is outlined with dashed white lines. Shown are clones transplanted
nor to WT host (D) and 2 ng gnl2MO-injected donor to 2 ng gnl2MO-injected host (E).
within transplanted clones for each of the experimental groups. Statistics: Two-tailed
the standard deviation. (G) Distribution of EdU+ cells within the clones of transplanted
ntage of EdU+ cells/bin was determined. Clones fromWT→WT andWT→gnl2mutant,
sal axis. In contrast, the distribution at bins 2 and 6 is signiﬁcantly different between
d Student's t-test. Error bars represent SEM. Scalebar 25 μm.
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298 J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301addition, p53 MO injection did not increase the total number of nuclei
in the gnl2 retina (Suppl. Fig. 6H). These data suggest that although
p53 stabilization is widely known to cause cell cycle arrest, this arrest
is not responsible for the delayed differentiation of the gnl2 mutant
retinal cells. In contrast, injection of p53MO into nsmutants increased
the number of RGCs in nsmutants and partially rescued the number of
retinal cells at 48 hpf (Suppl. Figs. 6C, F, I and J). However, the
patterning of the GCL was not rescued as the GCL had not extended
properly around the lens in ns/p53 compound mutants at 72 hpf
(Figs. 6J, M, P and S). These data suggest that the delayed neuronal
differentiation phenotype in gnl2 and ns mutants occurs mainly
independently of p53 activation.
Gnl2 and NS have both non-autonomous and cell-autonomous functions
in retinal progenitor cell cycle exit and differentiation
Since the delayed cell cycle exit and neuronal differentiation in
gnl2 and ns mutants occur independently of p53 activation, we next
examined whether Gnl2 and NS act cell-autonomously or non-cell
autonomously in retina progenitors by mosaic analysis. Cells from
labeled sphere-stage embryos were transplanted into the prospective
eye ﬁelds of unlabelled shield-stage host embryos (Fig. 7A). At 48 hpf,
the transplanted host embryos were exposed to a short pulse of EdU
to determine the proportion of cells in S-phase. Subsequently,
transplanted embryos were examined for the EdU incorporation and
the expression of the RGC marker zn8 (Suppl. Table 2).
As expected, most of the cells derived from WT donors that were
transplanted inWT host retinae had exited the cell cycle by 48 hpf and
±20% of cells had differentiated into RGCs (Figs. 7B and F).
Intriguingly, when WT cells were transplanted into gnl2 or ns
mutant retinae, the proportion of EdU+ cells in WT clones was
increased as compared to WT clones in a WT environment (Figs. 7C
and F; Suppl. Figs. 7A–D). In addition, the proportion of differentiated
RGCs in WT to gnl2 or WT to ns transplantations was reduced. In very
large clones (N300 cells), in a subset of cases, RGCs seemed to be
induced in the middle of the clone (Suppl. Figs. 7F and G). However,
more EdU+ cells were present in these clones than in large clones of
WT cells inWT environments. These data suggest that Gnl2 and NS act
non-cell autonomously.
In all transplantation experiments (for each mutant N200 host
embryos transplanted with cells derived from the progeny of
heterozygous parents), there were exceptionally few host embryos
with healthy-looking transplanted cells derived from gnl2 or ns
mutant hosts. Also, in the embryos that did contain living mutant
transplanted cells, in the majority of embryos, these living cells were
present in the brain, but seldom in the retina. The only embryo
containing living transplanted gnl2 donor cells in a WT retina
contained only a very small clone (12 cells). In this embryo, the
mutant cells were able to differentiate into RGCs and only few cells
were proliferating (Suppl. Fig. 7E). These data suggest that gnl2 and ns
mutant cells are very sensitive to induction of cell death upon
transplantation, especially when targeted to a WT retina environ-
ment. To circumvent this, we used gnl2 MO injection to evaluate the
behavior of gnl2-reduced cells in WT and gnl2 mutant environments.
Embryos injected with 2 or 5 ng of gnl2 MO showed a mild to severe
gnl2 mutant-like phenotype, respectively, with regards to EdU
incorporation and RGC differentiation (data not shown). Transplan-
tation of WT cells into host embryos that had been injected with 5 ng
of gnl2 MO showed reduced cell cycle exit and RGC differentiation
(Suppl. Figs. 7E and H), conﬁrming the results of the transplantation
of WT into gnl2 mutant environments. The proportion of EdU+ and
zn8+ cells in WT clones in 5 ng gnl2 MO environment was very
similar to that of 5 ng gnl2 MO clones in 5 ng gnl2 MO environment
(Suppl. Figs. 7E and I). Unfortunately, no WT host retinae (N150
total transplanted WT hosts) were observed to contain cells derived
from 5 ng gnl2 MO-injected donors, suggesting that similar to gnl2mutant cells, the morphant cells also died upon transplantation into
WT retinae.
When cells derived from donors injected with 2 ng gnl2 MO were
transplanted, there were a small number of WT embryos containing
small clones of living transplanted cells in the retina (Figs. 7D and F).
In these embryos, the transplanted morphant cells showed a
signiﬁcantly reduced proportion of EdU+ cells and increased
numbers of differentiated RGCs as compared to clones from 2 ng
gnl2 MO-injected donors in gnl2 mutant retinae (Figs. 7E and F),
suggesting that these morphant cells show increased cell cycle exit
and RGC differentiation when placed in WT, but not mutant
environments. Although the proportion of EdU+ cells in clones of
gnl2morphant cells in WT retinae was decreased as compared to cells
in mutant retinae, the proportion of EdU+ cells was still signiﬁcantly
higher (pb0.02) as compared to transplanted WT cells (Fig. 7F),
suggesting that in this context Gnl2 also has some cell-autonomous
function in cell cycle exit.
Next to the proportion of EdU+ cells within the clones, the
distribution of EdU+ cells along the apico-basal axis within the clones
was very similar between WT clones into WT host and gnl2 MO into
WT on the one hand and WT into gnl2 and gnl2 MO into gnl2 host
embryos on the other hand (Fig. 7G). These data conﬁrm the non-cell
autonomous function of Gnl2 in cell cycle exit and RGC differentiation.
Since the EdU detection method as used for the mosaic analysis
experiments does not require denaturation and subsequent antibody
detection (as with BrdU), but rather is a simple chemical ‘click’
reaction, this probably allows for determining quantitative differences
in EdU incorporation representing differences in DNA synthesis
between samples (Mahler et al., 2010; Salic and Mitchison, 2008).
Indeed, when comparing the EdU label intensity betweenWT and gnl2
or ns mutant retinae, considerable differences in EdU label intensity
were observed that were not observed in the experiments using BrdU.
In WT cells, two distinct EdU label patterns could be observed that
represent the distinct phase of S-phase during the EdU exposure
(Fig. 7B, Suppl. Fig. 7A). Some WT cells showed a punctate pattern of
EdU incorporation, suggesting that these cells were only incorporat-
ing EdU for a limited time within the duration of the EdU pulse,
probably at the very beginning or very end of the DNA synthesis stage.
Other cells showed a more evenly distributed EdU label, suggesting
that these cells were incorporating EdU for the whole duration of the
EdU pulse. In contrast, the EdU label intensity was generally much
lower in mutant cells and seemed to be more evenly distributed over
the nuclei (especially in gnl2 mutants; Fig. 7E, Suppl. Fig. 7B). This
might reﬂect slower EdU incorporation due to slower DNA synthesis
rates. Interestingly, the intensity difference remained noticeable in
the transplantation experiments. The EdU intensity of transplanted
WT cells in gnl2 or ns mutant retinae was clearly much higher
compared to surrounding mutant cells for all WT clones in all mutant
embryos examined (Fig. 7C, Suppl. Fig. 7B and 8), suggesting that the
effect of gnl2 or ns depletion on EdU incorporation is cell-autonomous.
Even in very large clones (N300 cells), this difference was apparent
(Suppl. Figs. 7F and G). Interestingly, in the 2 ng gnl2MO clones inWT
retinae, there was no apparent difference in EdU intensity between
transplanted and directly surrounding cells (Suppl. Fig. 8F). Since we
could not examine the EdU intensity of mutant cells in a WT
environment, the cell-autonomous nature of the EdU intensity
phenotype cannot be concluded with certainty.Discussion
Nucleostemin has recently received a great deal of attention in the
ﬁeld of stem cells and cancer biology due to its role in maintenance of
proliferation and its high expression in actively proliferating cells.
However, the functions of the related protein Gnl2 have not been
characterized in detail.
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retina results in the failure of cells to exit the cell cycle and subsequent
delayed terminal differentiation. In contrast, premature cell cycle exit
and neuronal differentiation takes place in the brain. These defects
appear to be linked to the aberrant expression of speciﬁc cell cycle
regulators and not to cell cycle arrest caused by the stabilization of
p53.
Partial redundancy between Gnl2 and NS was suggested by the
synergistic worsening of the retinal differentiation phenotype in
compound gnl2/ns mutants as compared to the respective single
mutants. In general, the gnl2 phenotype regarding p53 stabilization
and retinal differentiation is more severe compared to the ns mutant
phenotype. This difference could be due to differential expression of
the two genes. This possibility is supported by the observation that ns
expression is more restricted than that of gnl2 during early
development (b48 hpf). Alternatively, the difference in phenotype
severity may reﬂect a differential contribution of maternal gnl2 versus
ns mRNA. Although further studies will be required to elucidate the
extent of the overlapping functions of NS and Gnl2, our results do
suggest that Gnl2 may in fact be more important than NS during
development of vertebrate embryos.
Loss of Gnl2 and NS results in p53 stabilization and p53-mediated
apoptosis
NS has recently been suggested to control p53 activity by binding
to the E3 ubiquitin ligase Mdm2 or by increasing ribosomal protein L5
and L11 binding to Mdm2 (Dai et al., 2008). We demonstrate that
depletion of NS and Gnl2 in the developing zebraﬁsh causes
stabilization of p53 and activation of p53 target genes. It has not
been investigated whether Gnl2 can directly interact with Mdm2
similarly to NS. Our results show that depletion of Gnl2 causes
stabilization of p53 protein as well as upregulation of the p53 target
genes ccng1 andmdm2, suggesting that such an interaction may exist.
Since survival of Ns−/− mice was not restored upon crossing the
mutants with p53 null mice, it was suggested that the relevance of
p53-related functions of NS in vivo is small (Beekman et al., 2006). We
show here that the induction of programmed cell death in gnl2 and ns
embryos is p53-dependent. This ﬁnding was corroborated by the
upregulation of several pro-apoptotic genes that are induced by p53
activity in the gnl2 expression proﬁle. However, similar to the murine
double Ns/p53 mutants, we were unable to rescue the lethal
phenotype of either the gnl2 or ns mutant embryos by p53 depletion
or by crossing the mutants with a loss of function p53 line. Moreover,
we show here that p53 reduction does not restore the timing of RGC
differentiation or survival of RGCs in gnl2 mutants and thus, that p53
activation does not play a role in the neural differentiation defects.
The RGC differentiation phenotype seemed initially improved upon
depletion of p53 in ns mutants. Possibly, the reduction in differenti-
ated neural cell types in the ns mutant retina is partially caused by
increased apoptosis due to p53 activation.
Previous studies have shown that p53 activation and subsequent
induction of apoptosis is common when ribosome biogenesis and
translation are disrupted (Azuma et al., 2006; Chakraborty et al.,
2009; Danilova et al., 2010; Skarie and Link, 2008; Zhang et al., 2003,
2008). Our and previous results show, however, that the direct
contribution of p53 activation to the reduced health of the mutant
retina appears to be small. Therefore, it seems probable that there
must be pathways other than p53 that contribute to reduced health
after cellular stresses such as reduced translation.
Gnl2 and NS are important for inducing timely cell cycle exit of neural
progenitors
We show that mutations in gnl2 or ns cause both delayed cell cycle
exit and neuronal differentiation of retinal precursors. In gnl2mutants, induction of RGC fate was delayed. In contrast, RGC fate
induction occurred normally in ns mutants. Previous studies have
suggested that expression of Ath5 or p57Kip2 by itself is not sufﬁcient
to induce RGC fate, suggesting that combined expression of proneural
genes with cell cycle inhibitors is required to promote neuronal
differentiation (Ohnuma et al., 2002; Shkumatava and Neumann,
2005). Therefore, the prolonged expression of a cell cycle activator
(ccnd1) in combination with prolonged incorporation of the S-phase
marker BrdU and delayed expression of a cell cycle inhibitor (cdkn1c/
p57kip2) in gnl2 and ns mutant retinae suggests that the delayed
differentiation is due to retinal precursors failing to exit the cell cycle
on time.
The mosaic analysis experiments show that disruption of gnl2 and
ns result in both autonomous and non-cell autonomous defects in
retinal development.
The non-cell autonomous aspects of the phenotype might reﬂect
the general impaired health of the retina due to disruption of
ribosome biogenesis that is known to result from loss of gnl2 or ns
(Bassler et al., 2001; Kudron and Reinke, 2008; Rosby et al., 2009;
Saveanu et al., 2001). Reduced translation has also been previously
shown to lead to delayed neurogenesis during development (Azuma
et al., 2006). Therefore, it is very likely that defective translation could
affect neuronal differentiation, perhaps by altering the status of
signaling pathway(s) known to regulate steps in neurogenesis.
Intriguingly, several aspects of the gnl2 and ns phenotypes appear
to be cell-autonomous, namely the very low survival of gnl2 and ns-
donor derived transplanted cells in WT environments and the
difference in EdU intensity. Also, it appears that Gnl2 and NS have a
speciﬁc cell-autonomous function in the regulation of cell cycle exit in
retinal progenitors. It is plausible that the Gnl2 and NS reduced cells
have diminished health due to disrupted ribosome biogenesis and
therefore, have reduced viability in comparison to surrounding
healthy WT cells. The increased EdU-intensity of WT versus mutant
cells that was conserved upon transplantation ofWT cells into mutant
environments and the increased proportion of EdU+ cells in
morphant cells transplanted in WT environments as compared to
transplanted WT cells suggests that there is a cell-autonomous
function of Gnl2 and NS in S-phase progression.
The abnormally high expression levels of ccnd1 in the gnl2 and ns
mutant retinae coupled to the increase in BrdU incorporation in the
central retinae of the mutants provides strong evidence that cells in
the mutant retinae are remaining in the cell cycle for a longer than
normal length of time. In gnl2 and to a lesser extent in nsmutants the
number of cells undergoing mitosis relative to the number of cells in
S-phase is decreased. This could mean that there is a delay or block in
G2-M phase progression. However, we did not observe a signiﬁcant
difference in the proportion of Ph3+/BrdU+ cells in gnl2 versus WT
embryos in a 6 h BrdU chase-experiment (data not shown), suggest-
ing that the G2-M phase progression is not affected. Alternately, an
increase in total cell cycle length could be due to a shortening of M-
phase or an increase in G1- or S-phase length. However, our results
indicate that the most likely cell cycle alteration is the extension of S-
phase length. The lower Edu intensity in gnl2 mutants versus WT
embryos could reﬂect a slower rate of DNA-synthesis in the mutants,
possibly by activation of the intra-S-phase checkpoint for DNA repair.
Therefore, more detailed analysis of the cell cycle and its regulators, in
particular of S-phase entry and progression, could elucidate the exact
role of Gnl2 and NS in regulation of cell cycle progression and exit.
Also, it will be interesting to study in more detail whether and how
Gnl2 and NS affect regulation of expression of cell cycle regulators
such as Ccnd1 and p57kip2 directly.
An interesting aspect of the gnl2 and ns mutants is the apparently
contradicting phenotype in the brain versus retina. In contrast to the
delayed cell cycle exit and decreased neuronal differentiation in the
retina, premature neuronal differentiation was observed in the gnl2
and ns brain (Fig. 1 and data not shown). A possible explanation is
300 J.T.M.L. Paridaen et al. / Developmental Biology 355 (2011) 286–301given by the observation that p57kip2 expression that is delayed in the
retina is actually premature in the brain. Since p57kip2 expression can
drive cell cycle exit and induce neuronal differentiation (Park et al.,
2005; Rothschild et al., 2006; Shkumatava and Neumann, 2005; Tury
et al., 2011), it is plausible that this might drive the premature
neuronal differentiation in the mutant brain. At this moment, we do
not know what causes this difference in regulation of p57kip2
expression levels. Another interesting observation regarding the
difference in brain versus retinal phenotype is that the survival of
mutant cells that were transplanted into theWT brain did not seem to
be impaired to the same extent to that of mutant cells transplanted
into the WT brain (data not shown). It will be interesting to study
these differences between the brain and retina phenotypes further.
In summary, we demonstrate in this study that loss of either Gnl2
or NS in the developing vertebrate results in aberrant expression of
cell cycle regulators, accompanied by delayed cell cycle exit and
differentiation. The function of Gnl2 and NS in cell cycle exit and
differentiation has both non-cell autonomous and cell-autonomous
aspects and is independent of p53 stabilization. Moreover, unper-
turbed function of the nucleolar GTP-binding protein Gnl2 appears to
be equally if not more important than that of NS for proper vertebrate
development. Further studies evaluating the distinct and overlapping
functions of Gnl2 and NS will be required to fully appreciate the roles
of each protein in the regulation of proliferation of stem and cancer
cells, as well as their roles in regulation of proliferation and
differentiation during vertebrate development.
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